Eversept Partners LP Acquires 36,000 Shares of Molina Healthcare, Inc $MOH

Eversept Partners LP grew its position in Molina Healthcare, Inc (NYSE:MOH) by 380.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 45,470 shares of the company’s stock after purchasing an additional 36,000 shares during the period. Eversept Partners LP’s holdings in Molina Healthcare were worth $7,891,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of MOH. Torren Management LLC purchased a new position in Molina Healthcare in the fourth quarter worth $26,000. Miller Global Investments LLC purchased a new position in Molina Healthcare in the fourth quarter worth $27,000. Cromwell Holdings LLC grew its holdings in Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after purchasing an additional 125 shares during the last quarter. Quarry LP purchased a new position in Molina Healthcare in the fourth quarter worth $32,000. Finally, Triumph Capital Management grew its holdings in Molina Healthcare by 4,625.0% in the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock worth $33,000 after purchasing an additional 185 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares of the company’s stock, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares in the company, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by insiders.

Molina Healthcare Price Performance

Shares of MOH opened at $195.39 on Thursday. The firm has a market capitalization of $10.18 billion, a PE ratio of 57.81 and a beta of 0.80. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $311.52. The company’s fifty day moving average price is $178.29 and its 200-day moving average price is $165.71.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. The firm had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same period in the previous year, the company earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, equities research analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. Robert W. Baird lifted their price target on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Wall Street Zen raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a report on Saturday, May 2nd. Barclays lifted their price target on shares of Molina Healthcare from $161.00 to $199.00 and gave the stock an “underweight” rating in a report on Tuesday, May 26th. Bank of America raised shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target on the stock in a report on Wednesday, April 29th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Molina Healthcare from $169.00 to $191.00 and gave the stock a “neutral” rating in a report on Monday, June 8th. Three investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Molina Healthcare currently has a consensus rating of “Hold” and an average target price of $182.73.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.